− HEALTH There is a growing literature on the prediction of risk of deterioration in hospital settings, including by l…− SCIENCE Self-driving cars increasingly rely on deep neural networks to achieve human-like driving 1-3 . The opacity o…+ HEALTH Objective This study aimed to develop a mitochondrial and hematopoiesis-related differentially expressed gene…− HEALTH Axial dissections of the thoracic artery are common causes of death in people diagnosed with aortic dissectio…− HEALTH Background Enfortumab vedotin (EV) has transformed treatment for advanced urothelial carcinoma (aUC), but out…− HEALTH Background Large language model (LLM)-generated hospital courses are increasingly integrated into electronic…− HEALTH Recent years have witnessed considerable progress in computer-aided drug discovery, driven by the incorporati…+ HEALTH Background To develop a machine learning model for early differentiation of primary immune thrombocytopenia (…
TruaceTracing the truth around AIFriday, September 4, 2026
Subscribe
TRV-2026-0976Version 1 · Certified

Written 2026-09-04 06:03:57 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0976
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-09-04T06:03:57.543039Z
status: published
lens: p_space
sector: health
headline: Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation
dek: Recent years have witnessed considerable progress in computer-aided drug discovery, driven by the incorporation of computational technologies within both academic and pharmaceutical environments. This evolution is marked by a significant accumulation of data pertaining to detailed three-dimensional structural information, ligand properties, and their interactions with therapeutic targets. The augmentation of computational capabilities and the accessibility of extensive chemical libraries containing billions of d…
gain_title: (none)
problem_title: Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation: Furthermore, advancements in deep learning methodologies are required to improve the accuracy of prediction concerning target functionalities and ligand characteristics, even when complete receptor structures are not available.
trace_subject: (none)
gain_reading: (none)
gain_evidence: (none)
problem_reading: Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation: Furthermore, advancements in deep learning methodologies are required to improve the accuracy of prediction concerning target functionalities and ligand characteristics, even when complete receptor structures are not available.
problem_evidence: (none)
quick_read: Recent years have witnessed considerable progress in computer-aided drug discovery, driven by the incorporation of computational technologies within both academic and pharmaceutical environments. This evolution is marked by a significant accumulation of data pertaining to detailed three-dimensional structural information, ligand properties, and their interactions with therapeutic targets.

Finally, it outlines future research directions for artificial intelligence-driven, ultra-high performance computing (UHPC) in drug discovery, offering new prospects for the economical creation of safer and more efficacious molecule-level therapies.
limitation: 
tag: Evidence-backed problem
key_points: Recent years have witnessed considerable progress in computer-aided drug discovery, driven by the incorporation of computational technologies within both academic and pharmaceutical environments. | This evolution is marked by a significant accumulation of data pertaining to detailed three-dimensional structural information, ligand properties, and their interactions with therapeutic targets. | The augmentation of computational capabilities and the accessibility of extensive chemical libraries containing billions of drug-like small molecules have further facilitated this transition.
rundown: Recent years have witnessed considerable progress in computer-aided drug discovery, driven by the incorporation of computational technologies within both academic and pharmaceutical environments. This evolution is marked by a significant accumulation of data pertaining to detailed three-dimensional structural information, ligand properties, and their interactions with therapeutic targets.

The augmentation of computational capabilities and the accessibility of extensive chemical libraries containing billions of drug-like small molecules have further facilitated this transition. To effectively utilize these resources, it is imperative to employ rapid computing methods for virtual screening, which encompass structure-driven in silico screening across vast molecular spaces, supported by efficient recurrent profiling techniques.
sources:
- peer_reviewed | Molecular Biomedicine | https://doi.org/10.1186/s43556-026-00498-1 | 2026-09-03
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
38e3a1761778755c71dd0d0eaa7b83ac09e839c141f797c897f1050e9110ef35
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0976 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.